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Abstract
Impaired cognitive function (CF) is common among patients with CHF and is an additional factor impairing the quality of 
life, adherence to treatment, and hence the clinical prognosis in this category of patients.
The aim of this work was to study the prognostic significance of individual cognitive tests, as well as their combination in 
patients with CHF with a reduced left ventricular ejection fraction (LV EF).
Materials and methods. The study was conducted in the Department of Heart Failure of National Scientific Center 
“M.D. Strazhesko Institute of Cardiology” National Academy of Medical Sciences of Ukraine, in the period from 01/01/2016 to 
04/27/2018. A total of 124 patients with CHF between the ages of 18 and 75 years, II-IV functional classes by NYHA were examined. 
The cognitive function was assessed using the Schulte test, Mini-Mental State Examination scale (MMSE); HADS scale. Cognitive 
dysfunction (CD) was considered as MMSE≤26 points. To construct the survival curves and the onset of the combined critical event 
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(death or hospitalization), the Kaplan – Meier method was used, the significance of the differences between the curves was deter-
mined using the log-rank criterion. Differences were considered statistically significant at p<0.05.
Results. The MMSE scale was highly informative regarding the prediction of survival and the onset of a combined critical 
event (death or hospitalization) in patients with CHF and reduced LVEF even after correction of the compared groups by age and 
functional class according to NYHA (p=0.025 and p=0.049, respectively). Using the same sample, Schulte showed low prognostic 
significance regarding survival and reliable informativeness regarding the onset of the combined critical event, which, however, was 
leveled after correcting the compared samples by age and functional class NYHA (p=0.798 and p=0.240, respectively). The inclusion 
in the prognostic algorithm of estimating the sum of points on the HADS depression scale allowed increasing the degree of reliability 
of differences between the compared groups of patients with CD and without CD in terms of both long-term survival and the onset 
of a combined critical event (death or hospitalization) (p=0.006 and p=0.001 respectively).
Conclusions. The MMSE scale is informative regarding the prediction of survival and the onset of a combined critical event 
in patients with CHF and reduced LVEF. Schulte’s test does not have the prognostic information indicated above, however, the in-
clusion in the algorithm of the sum of points on the HADS depression scale allows to increase the degree of statistical confidence in 
the compared groups.
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1. Introduction
To date, chronic heart failure (CHF) is one of the most important problems of modern car-
diology, which is largely due to its poor clinical prognosis. The mortality rate from CHF in the 
first five years after diagnosis has reached 59 % among men and 45 % among women. One out of 
4–5 patients dies within the first year after the diagnosis of CHF is diagnosed [1]. In this context, 
the importance of determining the role of various factors that can influence the course and progno-
sis of this disease is of great importance in CHF.
Impaired cognitive function (CF) is common among patients with CHF [2] and is an addi-
tional factor impairing the quality of life, adherence to treatment, and, consequently, the clinical 
prognosis in this category of patients [3]. It is known that the presence of cognitive dysfunction 
(CD) increases hospital and non-hospital mortality of patients with CHF, so in the study of Zuccala 
and co-authors the hospital mortality rate of patients with HF was almost 5 times higher in the 
presence of CD [4].
For the assessment of CF, various screening neuropsychological tests are used, which make 
it possible to assess the status of CF, without the obligatory involvement of a narrow specialist. The 
most widely used of them in clinical practice today are the brief scale for assessing mental status – 
MMSE (MiniMentalStateExamination) [5] and the Schulte’s test [6].
Therefore, if the prognostic value of the fact of the presence of a CD has been established, 
then the corresponding prognostic information content of the results of individual cognitive tests 
has not been previously studied. This approach seems relevant from the standpoint of optimizing 
individual prediction of clinical outcomes of CHF.
2. Aim of the research
Study of the significance of individual cognitive tests, as well as their combination in pa-
tients with CHF with a reduced left ventricular ejection fraction (LVEF) for predicting long-term 
survival and the onset of a combined critical event (death or hospitalization).
3. Materials and methods
The study was conducted in the department of heart failure of National Scientific Center 
“M. D. Strazhesko Institute of Cardiology” National Academy of Medical Sciences of Ukraine, in 
the period from 01/01/2016 to 04/27/2018. The length of observation period was 27.5 months. The 
beginning of the observation was considered the date of primary hospitalization, the end point – the 
date of the patient’s death or survival by April 27, 2018. The survival of the subjects was assessed 
using a telephone survey or postal correspondence.
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We examined 124 patients with stable CHF and reduced LV EF (<40 %) (Me=28.0 (21; 35)) 
aged 25 to 75 years (Me=63.0 (54; 68.3)) those who were hospitalized in the department of heart 
failure of the State Institution National Research Center “Institute of Cardiology named after acad. 
N. D. Strazhesko”. Among the studied men dominated – 83 % (103 people). Etiological factor in 
the development of CHF was coronary heart disease (CHD) (94 people) or dilated cardiomyopathy 
(DCM) (19 people). A history of concomitant arterial hypertension (AH) was 92 people, diabetes 
mellitus (DM) – 35 people. About half of the patients had a permanent or persistent form of atrial 
fibrillation (AF) (Table 1).
The study did not include patients older than 75 years, with an acute violation of cerebral cir-
culation in history, with organic brain lesions (traumatic brain injury, infectious diseases, tumors, 
etc.), with neurodegenerative diseases (Alzheimer’s disease, Parkinson’s and others) with cancer 
and infectious diseases, with hypertrophic cardiomyopathy, inflammatory and restrictive myocar-
dial lesions, with acute coronary syndrome, myocardial infarction (MI) older than 3 months, with 
retained organic and congenital heart defects, as well as those who took drugs that can affect the 
CF (except for drugs that are part of the standard treatment protocol for heart failure).
The diagnosis of the underlying disease was determined on the basis of general clinical ex-
amination, instrumental and laboratory methods. CHF was diagnosed according to the recommen-
dations for the diagnosis and treatment of heart failure of the European Society of Cardiology and 
the relevant recommendations of the Association of Cardiologists of Ukraine [7–9]. Patients were 
included in the study in the phase of clinical compensation while receiving optimized standard 
pharmacotherapy (ACE inhibitors, sartans, beta-blockers, mineralcorticoid receptor antagonists, 
diuretics). The observation period was 27.5 months.
The compulsory examination protocol included electrocardiography, standard echocardiog-
raphy, routine laboratory tests for determining glomerular filtration rate (GFR) using the EPI for-
mula [10], quality of life assessment using the Minnesota Living with Heart Failure Questionnaire 
(MLHFQ) questionnaire activity – DukeActivityStatusIndex (DASI) using the Duke University 
questionnaire [11, 12]. To assess the state of CF, standardized methods of neuropsychological test-
ing were used – the abbreviated scale of the mental status study Mini-Mental State Examination 
(MMSE), Schulte’s test [5, 13]; using the HADS scale, levels of depression and anxiety were as-
sessed [14, 15].
Statistical processing of information was carried out using Microsoft Exel, IBM-
SPSSStatistics (version 22.0). The normal distribution was estimated using the Kolmogor-
ov-Smirnov test. Since the distribution of intragroup quantitative indicators, as a rule, differed 
from the normal, the median and interquartile range (Me (LQ; UQ)) were used for the descrip-
tion. The absolute and relative frequencies (n, %) were calculated to describe the qualitative 
features. The hypothesis about the reliability of the difference in the values of quantitative 
indicators in the compared groups was checked using the non-parametric Mann-Whitney test, 
for qualitative ones using the χ2-Pearson criterion with the construction of contingency tables. 
To construct the survival curves and the onset of a combined critical event (death or hospital-
ization), the Kaplan-Meier method [16] was used, the significance of the differences between 
the curves was determined using the log-rank criterion [17]. Differences were considered sta-
tistically significant at p<0.05.
4. Results
The criterion for the presence of the CD was the number of points on the scale of MMSE 
≤26. It is noteworthy that the median score on the MMSE scale also amounted to 26.
Among the studied CDs according to the MMSE test, there was in most cases, that is, in 
85 (68.6 %) patients examined. The studied groups were comparable in terms of gender, prevalence 
of persistent/persistent forms of AF, and concomitant pathology – anemia, chronic obstructive pul-
monary disease (COPD), and diabetes mellitus (DM) (Table 1).
At the same time, patients with more severe functional class according to NYHA (III–IV) 
prevailed among those studied with CD (Table 1).
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Comparability of patient groups with and without CD in terms of gender composition, distribution by 
functional classes and comorbidities
Indicators
Patients with CD (n=85) Patients without CD (n=39)
P
n % n %
Men, (n=103) 68 80 35 89.7 0.210
NYHA II FC (n=44) 22 25.9 22 56.4 0.001
NYHA III–IV FC (n=80) 63 74.1 17 43.6 0.001
AF (n=68) 51 60 17 43.6 0.066
DM (n=35) 28 32.9 7 17.9 0.055
COPD (n=21) 14 16.5 7 17.9 0.513
Anemia (n=36) 27 31.8 9 23.1 0.220
Note: AF – atrial fibrillation; DM – diabetes mellitus; COPD – chronic obstructive pulmonary disease
According to hemodynamic parameters – the value of systolic (SBP) and diastolic (DBP) 
blood pressure, heart rate (HR) and the LV EF value, the studied groups were comparable. Howev-
er, among patients with CD, the older age group prevailed (Table 2).
Table 2
Comparability of patient groups with and without CD in terms of age and hemodynamic parameters
Indicators CD (MMSE≤26 points) (n=85)  
Me (LQ; HQ)
Without CD (MMSE>26 points) (n=39) 
Me (LQ; HQ)
P
Age, years 64 (57; 69,5) 55 (44; 64) 0.002
HR, bpm 75 (68; 85) 74 (68; 82) 0.461
SBP, mm Hg 110 (105; 120) 110 (100; 120) 0.476
DBP, mm Hg 80 (70; 85) 70 (70; 80) 0.264
LV EF, % 29 (22; 35) 27 (21; 35) 0.637
Note: HR – heart rate; SBP – systolic blood pressure; DBP – diastolic blood pressure; LV EF – left ventricular ejection fraction
During the first stage of work, we studied the long-term clinical prognosis of patients with 
CHF, depending on the presence of CD.
As seen in Fig. 1, the group of patients with CD had a significantly worse clinical prognosis 
in relation to the onset of death, compared with patients without CD.
In Fig. 2 shows that patients with CD had a significantly worse clinical prognosis regarding 
the onset of a combined critical event (death or hospitalization).
The next stage of work was the comparison of the survival curves and the onset of the 
combined critical event for groups of patients with CD and without CD after leveling them up by 
age and functional class according to NYHA, which, as is known, are themselves markers of an 
unfavorable clinical prognosis of patients with CHF [18].
After correction of the compared groups of patients by age and NYHA functional class, 
significant differences in survival and the onset of the combined critical event persisted, which 
indicates the effect on the worst prognosis of the CD (Fig. 3, 4).
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Fig. 1. Survival curves of patients with CHF and reduced LV EF depending on the presence of CD, 
p=0.043; censored with and without a CD – the subjects who did not die at the time of the end of the 
observation period; CD – cognitive dysfunction; without CD – without cognitive dysfunction
Fig. 2. Curves of the onset of the combined critical event (death or hospitalization) depending on 
the presence of the CD, p=0.026: censored with CD and without CD are the subjects that did not 
have the combined critical event at the end of the observation period
Fig. 3. Survival curves of patients with CHF and reduced LV EF depending on the presence of 




















































































Fig. 4. Curves of the onset of the combined critical event (death or hospitalization), depending on 
the presence of CD, after correction of the compared groups by age and FC by the NYHA
At the next stage of our work, we tried to determine the effect of the time taken for the 
Schulte’s test to perform on the clinical prognosis of patients with CHF. To this end, we divided 
the subjects into 2 groups according to the median (54, 15) execution time of the Schulte’s sample: 
≤54.15 seconds. (n=62) and >54.15 sec. (n=62). It should be noted that in individuals with CD, the 
median of the Schulte’s sample execution time was 61 seconds (min-32 s; max-110 s).
As seen in Fig. 5, 6, the time taken to Schulte’s test did not significantly affect the mortal-
ity rate of patients with CHF, while the incidence of the combined critical event was significantly 
higher in the group of patients with the worst performance of the Schulte’s test. However, this 
difference was leveled after grading of the studied groups according to age and NYHA class 
(Fig. 7, 8).
Fig. 5. Survival curves for patients with CHF and reduced LV EF depending on the median of  
the time taken for the Schulte’s test.
At the same time, when dividing patients into two groups according to a combination of two 
signs, such as “the time for performing the Schulte’s test> medians (54.15)” + “the sum of points 
for the HADS depression> medians (6)” (n=39 vs n=85) allowed to increase the degree of statistical 
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event (Fig. 9, 10). It should be noted that in individuals with CD, the median amount of points in 
the base of the HADS depression was 7 (min=0; max=16 points).
Fig. 6. Curves of the onset of the combined critical event (death or hospitalization) depending on 
the median of the time of the execution of the Schulte’s sample
Fig. 7. Survival curves for patients with CHF and reduced LV EF for the patient, depending on 
the median of the time taken to complete the Schulte’s test after correcting the groups for age and 
FC by the NYHA
Fig. 8. Curves of the onset of the combined critical event (death or hospitalization) depending on the 
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Fig. 9. Survival curves of patients with CHF and reduced LV EF when divided into groups by 
a combination of 2 signs – “time to perform a Schulte’s test> medians” + “sum of points on the 
base of the HADS depression> medians”
Fig. 10. Curves of the onset of the combined critical event (death or hospitalization) of patients 
with chronic heart failure and reduced LV EF when divided into groups by a combination of  
2 signs – “time to perform a Schulte’s test> medians” + “sum of points on the base of the HADS 
depression> medians”
5. Discussion
The study allowed us to confirm previously obtained data that the presence of CD is asso-
ciated with poorer survival and higher hospitalization rates for patients with CHF and reduced LV 
EF [3]. At the same time, our analysis of the prognostic significance of individual indicators of CF, 
along with confirmation of the prognostic validity of the total score on the MMSE scale, made it 
possible to state that there is no reliable relationship between the time when the Schulte’s sample 
was run and the long-term prognosis of our patients.
Along with this, we obtained data that the inclusion in the prognostic algorithm for estimat-
ing the sum of points by the base of the HADS depression allowed increasing the degree of reli-
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data on the close relationship of CD and depressive manifestations in patients with CHF [20]. It has 
been established that the role of depression in the formation of CD is very significant and consists, 
including in reducing motivational incentives for the assimilation and processing of information 
[21]. Depression negatively affects not only the prognosis of CHF, but also its clinical course [22]. 
A number of authors demonstrated the effect of depression on mortality, functional status and qual-
ity of life of patients with CHF in proportion to the severity of depressive symptoms [23, 24]. In 
patients with severe depression, the risk of death within 6 years is 2.5 times higher than in patients 
without depression [25]. J. Jünger et al. found that depression is a risk factor for death, regardless 
of the functional class of CHF, LV EF, and peak oxygen consumption [26].
The obtained data can serve as a basis for the next stage of work, consisting in clarifying 
the possibilities of a comprehensive assessment of the psychological and emotional status in its part 
concerning the state of CF and the presence / severity of depressive manifestations, with the aim of 
individually predicting the outcomes of this syndrome.
6. Conclusions
1. The MMSE scale is highly informative regarding the prediction of long-term survival 
and the onset of a combined critical event (mortality or hospitalization) in patients with CHF and 
reduced LV EF even after correction of the compared groups by age and NYHA functional class.
2. The use of Schulte’s test showed a low prognostic value regarding survival; its use demon-
strated sufficient informativeness regarding the onset of the combined critical event, which, howev-
er, was leveled after correction of the compared samples by age and NYHA functional class.
3. The inclusion in the prognostic algorithm of estimating the sum of points of the HADS 
depression scale allows to increase the degree of reliability of differences between the compared 
groups of patients with CD and non-CD both in terms of long-term survival and the onset of a 
combined critical event (mortality or hospitalization).
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